New York Magazine @NYMag
@MrJDWalsh The slow start is due, at least in part, to the fact that 1.1 million doses have been stored in a Denmark pharmaceutical facility while the FDA has taken almost two months to approve their release here, according to people familiar with the situation https://t.co/wEQJg7ZFAg — PolitiTweet.org